ID
29909
Description
Study ID: 108414 Clinical Study ID: DBU108414 Study Title: TXA107979: A placebo-controlled, single blind, randomized two part study to investigate the tolerability, pharmacokinetics, and brainDopamine D3 receptor occupancy of increasing repeat doses ofGSK618334 for up to 21 days in healthy volunteers. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01036061 https://clinicaltrials.gov/ct2/show/NCT01036061 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK618334 Study Indication: Substance Dependence Documentation part: Local Laboratory
Link
https://clinicaltrials.gov/ct2/show/NCT01036061
Keywords
Versions (1)
- 4/26/18 4/26/18 -
Copyright Holder
GlaxoSmithKline
Uploaded on
April 26, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Tolerability, pharmacokinetics, and brain Dopamine D3 receptor occupancy of increasing repeat doses of GSK618334 in healthy adults NCT01036061
Local Laboratory
- StudyEvent: ODM
Description
Local Laboratory Results
Alias
- UMLS CUI-1
- C1254595
Description
Laboratory Test
Data type
integer
Alias
- UMLS CUI [1,1]
- C0022885
- UMLS CUI [1,2]
- C0332307
Description
Clinical Chemistry result
Data type
text
Alias
- UMLS CUI [1,1]
- C0008000
- UMLS CUI [1,2]
- C1254595
Description
Haematology result
Data type
text
Alias
- UMLS CUI [1]
- C0474523
Description
Type of result
Data type
integer
Alias
- UMLS CUI [1,1]
- C1254595
- UMLS CUI [1,2]
- C0332307
Similar models
Local Laboratory
- StudyEvent: ODM
C0040223 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,3])
C1254595 (UMLS CUI [1,2])